(Q34744239)

4 August 2017

1 reference

title

Current state of pneumococcal vaccines (English)

1 reference

4 August 2017

1 reference

2

Käyhty H

1 reference

4 August 2017

Wuorimaa T

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

Scandinavian Journal of Immunology

4 August 2017

published in

1 reference

4 August 2017

volume

56

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

111-129

1 reference

Pneumococcal nasopharyngeal colonization in young South Indian infants

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Bacterial and viral etiology of acute otitis media in Chilean children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Clinical course, complications and sequelae of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Etiology of childhood pneumonia: serologic results of a prospective, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Epidemiology of invasive pneumococcal infections in children in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Bacterial meningitis in the United States in 1995. Active Surveillance Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pneumococcal conjugate vaccines in Europe, Berlin, Germany, 23-25 August 2000. Report of a European advisory board meeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Invasive pneumococcal disease in England and Wales: vaccination implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Antibiotic treatment in acute Otitis Media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Penicillin-resistant pneumococci in southern Sweden, 1993-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Molecular typing of Streptococcus pneumoniae in northeastern Romania: unique clones of S. pneumoniae isolated from children hospitalized for infections and from healthy and human immunodeficiency virus-infected children in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Thymus-independent and thymus-dependent responses to polysaccharide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Adverse reactions to polyvalent pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Prevention of otitis media in children by pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pneumococcal antibody responses in elite swimmers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pneumococcal carriage and type-specific antibody. Failure of a 14-valent vaccine to reduce carriage in healthy children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The development of B cells and the B-cell repertoire in the microenvironment of the germinal center

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Maturation and dispersal of B-cell clones during T cell-dependent antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The maturation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Distinct role of follicular dendritic cells and T cells in the proliferation, differentiation, and apoptosis of a centroblast cell line, L3055.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Memory B-cell persistence is independent of persisting immunizing antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Long-lived plasma cells: a mechanism for maintaining persistent antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

New vaccines for the prevention of pneumococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

The pneumococcal protein conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Potential alterations in immunogenicity by combining or simultaneously administering vaccine components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Adjuvants for human vaccines--current status, problems and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Neonatal and early life vaccinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immunogenicity of pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Immune Response to Pneumococcal Conjugate and Polysaccharide Vaccines in Otitis‐Prone and Otitis‐Free Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Clinical relevance of lower Hib response in DTPa-based combination vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

A Longitudinal Study of the Nasopharyngeal Carriage of Pneumococci as Related to Pneumococcal Vaccination in Children Attending Day-care Centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Cellular Interactions Involved in Th Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

Comparison of an Opsonophagocytic Assay and IgG ELISA to Assess Responses to Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccines in Children and Young Adults with Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2002.01124.X

10.1046/J.1365-3083.2002.01124.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference